Table 2.
In vivo techniques of angiogenesis.
| In vivo techniques | Type of methods | Biological scope | Assay reliability (quantitative or qualitative) | Pros/cons | References |
|---|---|---|---|---|---|
| Quantitative determination of tissue blood flow rate | Tissue blood flow rate | The process of delivering the arterial blood into the capillary beds within a scrupulous group of tissues | Measure the rate of delivery of an agent carried to the tissue by blood flow | More sensitive and acquires an appropriate pharmacodynamic endpoint | [109] |
| Fluorescent DNA-binding staining Hoechst 33342 | To measure perfused vascular volume as a fraction of the total tissue volume | Functional vessels appear as fluorescent halos after intravenous injection of the radioactive dye | Unable to discriminate between perfused vessels with different flow rates and lacks appropriate sensitivity | [68] | |
| In vivo Matrigel migration and angiogenesis assay | Marine Matrigel plug assay | Measuring angiogenesis and anti-angiogenesis | Quantitative method | Gives the best results when testing putative antiangiogenic compounds | [72] |
| Corneal pocket assay | Corneal assay | Implanted into a micropocket produced in the cornea thickness to induce angiogenesis by vascular outgrowths from peripherally located limbic vasculature | Characterization of angiogenesis inducers, evaluation of angiogenesis inhibitors, interaction between different factors, and study of cellular, biochemical, and molecular mechanisms of angiogenesis | Simple assay, shows excellent reproducibility compared to other in vivo assays Lack of blood vessels |
[82] |
| Other in vivo models | Mouse syngeneic models, human xenografts, transgenic mouse models, and mutagenesis-induced mouse models | To monitor the blood of the tumor in real time and accompanying cellular events that coincided with pharmacodynamic endpoints | — | — | [88] |